Nuvation Bio Inc Class A (NUVB) returns
Nuvation Bio returns over 5 years
$1,000 invested in Nuvation Bio five years ago was worth $519.08 at the close on October 30, 2026, with dividends reinvested: an average return of -12.3% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -15.0% | — | $850.00 | -0.9% |
| 3 months | -29.0% | — | $710.45 | +2.1% |
| Year to date | -46.9% | — | $531.25 | +11.7% |
| 1 year | -7.6% | — | $924.27 | +12.4% |
| 3 years | +376.0% | +68.2% | $4,760 | +88.5% |
| 5 years | -48.1% | -12.3% | $519.08 | +76.0% |
Nuvation Bio return by calendar year
| Year | NUVB | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -46.9% | +11.7% | -58.6% |
| 2025 | +236.8% | +17.7% | +219.1% |
| 2024 | +76.2% | +24.9% | +51.3% |
| 2023 | -21.4% | +26.2% | -47.5% |
| 2022 | -77.4% | -18.2% | -59.2% |
| 2021 | -27.4% | +28.7% | -56.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Nuvation Bio Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.